Literature DB >> 17595500

Rheumatic fever and rheumatic heart disease: primary prevention is the cost effective option.

M B Soudarssanane1, M Karthigeyan, T Mahalakshmy, Ajit Sahai, S Srinivasan, K S V K Subba Rao, J Balachander.   

Abstract

OBJECTIVE: To measure the economic output/input ratios for the various options of prevention of rheumatic fever/rheumatic heart disease (RF/RHD) and check the viability of primary prevention vis-à-vis secondary and tertiary preventions.
METHODS: Cost accounting of the various prevention options was calculated for each variable as available in literature. Actual data as obtainable for the financial year ending March 2006 were computed for the Pondicherry population. Both direct and indirect costs (including community/social costs) were worked out using mostly primary data and wherever necessary, secondary data. Certain scientific assumptions were used where exact data was not available.
RESULTS: Primary prevention is the definite viable economic option (1:1.56) compared to secondary (1: 1.07) and tertiary (1: 0.12) preventions. In fact, the current stress on only secondary and tertiary preventions is found to be economically unviable.
CONCLUSION: It is postulated that primary prevention as a practical policy in tackling RF and RHD can be recommended.

Entities:  

Mesh:

Year:  2007        PMID: 17595500     DOI: 10.1007/s12098-007-0094-y

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


  5 in total

1.  Rheumatic fever and rheumatic heart disease in India at the turn of the century.

Authors:  S Padmavati
Journal:  Indian Heart J       Date:  2001 Jan-Feb

2.  Group A streptococcal sore throat in a periurban population of northern India: a one-year prospective study.

Authors:  S Nandi; R Kumar; P Ray; H Vohra; N K Ganguly
Journal:  Bull World Health Organ       Date:  2001       Impact factor: 9.408

3.  Rheumatic fever and rheumatic heart disease. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1988

4.  Rheumatic heart disease in developing countries: the consequence of inadequate prevention.

Authors:  M J McLaren; M Markowitz; M A Gerber
Journal:  Ann Intern Med       Date:  1994-02-01       Impact factor: 25.391

5.  Rheumatic fever and rheumatic heart disease: clinical profile of 550 cases in India.

Authors:  M S Ravisha; Milind S Tullu; Jaishree R Kamat
Journal:  Arch Med Res       Date:  2003 Sep-Oct       Impact factor: 2.235

  5 in total
  11 in total

1.  Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model.

Authors:  Justin P Zachariah; Mihail Samnaliev
Journal:  J Med Econ       Date:  2015-02-09       Impact factor: 2.448

Review 2.  Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease.

Authors:  Bo Remenyi; Jonathan Carapetis; Rosemary Wyber; Kathryn Taubert; Bongani M Mayosi
Journal:  Nat Rev Cardiol       Date:  2013-04-02       Impact factor: 32.419

Review 3.  Heart failure: epidemiology and prevention in India.

Authors:  Mark D Huffman; Dorairaj Prabhakaran
Journal:  Natl Med J India       Date:  2010 Sep-Oct       Impact factor: 0.537

Review 4.  Cutting edge issues in rheumatic fever.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 5.  Rheumatic heart disease: progress and challenges in India.

Authors:  Bela Shah; Meenakshi Sharma; Rajesh Kumar; K N Brahmadathan; Vinod Joseph Abraham; Rajan Tandon
Journal:  Indian J Pediatr       Date:  2012-09-02       Impact factor: 1.967

6.  A frank statement on the health economics franchise.

Authors:  Manicassamy B Soudarssanane
Journal:  Indian J Community Med       Date:  2008-10

Review 7.  Heart failure in South Asia.

Authors:  Harikrishnan Sivadasan Pillai; Sanjay Ganapathi
Journal:  Curr Cardiol Rev       Date:  2013-05

Review 8.  Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review.

Authors:  Elizabeth D Brouwer; David Watkins; Zachary Olson; Jane Goett; Rachel Nugent; Carol Levin
Journal:  BMC Public Health       Date:  2015-11-26       Impact factor: 3.295

9.  A cost-effectiveness analysis of a program to control rheumatic fever and rheumatic heart disease in Pinar del Rio, Cuba.

Authors:  David A Watkins; Mercy Mvundura; Porfirio Nordet; Bongani M Mayosi
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

10.  Preventive interventions to reduce the burden of rheumatic heart disease in populations at risk: a systematic review protocol.

Authors:  Panduleni Penipawa Shimanda; Tonderai Washington Shumba; Mattias Brunström; Stefan Söderberg; Lars Lindholm; Scholastika Ndatinda Iipinge; Fredrik Norström
Journal:  Syst Rev       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.